Drug Delivery Technology Development in Canada

• Pubblicazione: MDPI - Multidisciplinary Digital Publishing Institute, 2019
• Descrizione fisica: 1 online resource (352 p.)
• Disciplina: 615.1/900971
• Soggetto topico: Medicine and Nursing
• Soggetto non controllato: 3D spheroid; adenanthin; amphotericin B; antibodies; bacteriophage; bioaccessibility; biodistribution; biological barriers; biologicals; blood-brain barrier; blood-brain barrier (BBB); Canada; cancer; canola oil deodorizer distillate; cationic gemini surfactant; child friendly formulation; chronotherapy; circadian clock; cisplatin; clinical trials; co-delivery; combination therapy; controlled drug delivery; developing world; dissolution; DOX-Vit D; doxorubicin; drug delivery; drug delivery systems; drug development; drug discovery; drug-resistant melanoma; EGFR-targeted therapy; emulsion; encapsulation; flavonoids; formulation and dosage form development; fungal infections; gambogic acid; gastrointestinal simulator; GE11 peptide; HAV6 cadherin peptide; head and neck squamous cell carcinoma; HIF-1; hypoxia-induced chemoresistance; inclusion complex; innovation; intra-arterial chemotherapy; lipid nanoparticles; liposome; liposomes; loading gradients; magnetic fields; magnetic resonance imaging (MRI); malignant gliomas; medical devices; medulloblastoma; mefloquine; melphalan; Metaplex; MG63; model orange juice; mouse models; nanoparticles; nifedipine; oral; oral delivery; oral formulation; parasitic infections; permeation enhancers; phage display; pharmaceutics; pharmacokinetics; pharmacological Inhibitors of HIF-1 and STAT3; phospholipid complex; photostabilizers; phytosterols; plant; polymeric micelle; precision medicine; primary central nervous system lymphomas; quercetin; radiation; radiolabeling; remote loading; ROESY NMR spectroscopy; rosmarinic acid; route of administration; skin; small molecules; STAT3; staurosporine; sustained delivery; targeted therapies; throughput; TNO gastrointestinal model; tocopherols; topical formulation; transdermal drug delivery; transient modulation; translational research; triggered drug release; ultrasound; virus; Vitamin D; water miscible solvents
• Persona (resp. second.): BadeaIldiko; WasanKishor M.
• Sommario/riassunto: Canada continues to have a rich history of ground-breaking research in drug delivery within academic institutions, pharmaceutical industry and the biotechnology community.
• Titolo autorizzato: Drug Delivery Technology Development in Canada
• ISBN: 3-03928-005-8
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910367736503321
• Lo trovi qui: Univ. Federico II